Melioidosis

Lancet

Volumn 361, Issue 9370, 2003, Pages 1715-1722

  White, N J ^a,b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFTAZIDIME; CHLORAMPHENICOL; COTRIMOXAZOLE; DOXYCYCLINE;

ASIA; AUSTRALIA; BACTERIOLOGY; BURKHOLDERIA PSEUDOMALLEI; CAUSE OF DEATH; CONFERENCE PAPER; DIABETES MELLITUS; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG CHOICE; DRUG SENSITIVITY; ENCEPHALITIS; EPIDEMIOLOGY; GRAM NEGATIVE BACTERIUM; HEALTH CARE; HUMAN; LIVER ABSCESS; LUNG ABSCESS; MEDICAL ASSESSMENT; MELIOIDOSIS; PATHOGENESIS; PREGNANCY; PRIORITY JOURNAL; PROBABILITY; PROSTATE; RELAPSE; SEPSIS; SEPTICEMIA; SKELETAL MUSCLE; SOIL; SPLEEN ABSCESS; THAILAND;

EID: 0038324480     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)13374-0     Document Type: Conference Paper

References (108)

1. Whitmore A., Krishnaswami C.S. An account of the discovery of a hitherto undescribed infective disease occurring among the population of Rangoon. Indian Med Gaz. 47:1912;262-267.
2. Whitmore A. An account of a glanders-like disease occurring in Rangoon. J Hyg. 13:1913;1-34.
3. Krishnaswami C.S. Morphia injectors' septicaemia. Indian Med Gaz. 52:1917;296-299.
4. Stanton A.T., Fletcher W. Melioidosis: studies from the Institute of Medical Research, Federated Malay States; 21. 1932;John Bale and Sons and Danielson Ltd, London.
5. Rubin H.L., Alexander A.D., Yager R.H. Melioidosis - a military medical problem? Mil Med. 128:1963;538-542.
6. Sanford J.P., Moore W.L. Recrudescent melioidosis, a Southeast Asian legacy? Am Rev Respir Dis. 104:1971;452-453.
7. Dance D.A.B. Melioidosis: the tip of the iceberg? Clin Microbiol Rev. 4:1991;52-60.
8. Dance D.A.B. Melioidosis. Rev Med Microbiol. 1:1990;143-150.
9. Leelarasamee A., Bovornkitti S. Melioidosis: review and update. Rev Infect Dis. 11:1989;413-425.
10. Chaowagul W., White N.J., Dance D.A., et al. Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J Infect Dis. 159:1989;890-899.
11. Phetsouvanh R., Phongmany S., Newton P., et al. Melioidosis and Pandora's box in Lao PDR. Clin Infect Dis. 32:2001;653-654.
12. Currie B.J., Fisher D.A., Howard D.M., et al. Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature. Clin Infect Dis. 31:2000;981-986.
13. Puthucheary S.D., Parasakthi N., Lee M.K. Septicaemic melioidosis: a review of 50 cases from Malaysia. Trans R Soc Trop Med Hyg. 86:1992;683-685.
14. Puthucheary S., Vadivelu J. Human Melioidosis. 2002;Singapore University Press.
15. Anonymous. Melioidosis in Singapore. Epidemiol News Bull (Singapore) 1995; 21: 69-72.
16. Heng B.H., Goh K.T., Yap E.H., Loh H., Yeo M. Epidemiological surveillance of melioidosis in Singapore. Ann Acad Med Singapore. 27:1998;478-484.
17. Dance D.A.B., White N.J. Melioidosis. Cox F.E.G. The Wellcome Trust illustrated history of tropical diseases. 1996;72-81 The Wellcome Trust, London.
18. Hsueh P.R., Teng L.J., Lee L.N., et al. Melioidosis: an emerging infection in Taiwan? Emerg Infect Dis. 7:2001;428-433.
19. Yang S. Melioidosis research in China. Acta Trop. 77:2000;157-165.
20. John T.J., Jesudason M.V., Lalitha M.K., et al. Melioidosis in India: the tip of the iceberg? Indian J Med Res. 103:1996;62-65.
21. Yabuuchi E., Kosako Y., Oyaizu H., et al. Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb nov. Microbiol Immunol. 36:1992;1251-1275.
22. Wuthiekanun V., Smith M.D., Dance D.A.B., White N.J. The isolation of Pseudomonas pseudomallei from soil in Northeastern Thailand. Trans R Soc Trop Med Hyg. 89:1995;41-43.
23. Ashdown L.R. An improved technique for isolation of Pseudomonas pseudomallei from clinical specimens. Pathology. 11:1979;293-297.
24. Walsh A.L., Wuthiekanun V. The laboratory diagnosis of melioidosis. Br J Biomed Sci. 53:1996;249-253.
25. Dance D.A., Wuthiekanun V., Naigowit P., White N.J. Identification of Pseudomonas pseudomallei in clinical practice: use of simple screening tests and API 20NE. J Clin Pathol. 42:1989;645-648.
26. Dance D.A.B., Wuthiekanun V., Chaowagul W., White N.J. The antimicrobial susceptibility of Pseudomonas pseudomallei: emergence of resistance in vitro and during treatment. J Antimicrob Chemother. 24:1989;295-309.
27. Jenney A.W., Lum G., Fisher D.A., Currie B.J. Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis. Int J Antimicrob Agents. 17:2001;109-113.
28. Piliouras P., Ulett G.C., Ashurst-Smith C., Hirst R.G., Norton R.E. A comparison of antibiotic susceptibility testing methods for cotrimoxazole with Burkholderia pseudomallei. Int J Antimicrob Agents. 19:2002;427-429.
29. Dance D.A.B., Wuthiekanun V., Chaowagul W., White N.J. Interactions in vitro between agents used to treat melioidosis. J Antimicrob Chemother. 24:1989;311-316.
30. Godfrey A.J., Wong S., Dance D.A., Chaowagul W., Bryan L.E. Pseudomonas pseudomallei resistance to beta-lactam antibiotics due to alterations in the chromosomally encoded beta-lactamase. Antimicrob Agents Chemother. 35:1991;1635-1640.
31. Moore R.A., DeShazer D., Reckseidler S., Weissman A., Woods D.E. Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrob Agents Chemother. 43:1999;465-470.
32. Simpson A.J.H., White N.J., Wuthiekanun V. Aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrob Agents Chemother. 43:1999;2332.
33. Ashdown L.R., Currie B.J. Melioidosis: when in doubt leave the quinolone alone! Med J Aust. 157:1992;427-428.
34. Chaowagul W., Suputtamongkol Y., Smith M.D., White N.J. Oral fluoroquinolones in the maintenance treatment of melioidosis. Trans R Soc Trop Med Hyg. 91:1997;599-601.
35. Wuthiekanun V., Smith M.D., White N.J. Survival of Burkholderia pseudomallei in the absence of nutrients. Trans R Soc Trop Med Hyg. 89:1995;491.
36. Woods D.E., DeShazer D., Moore R.A., et al. Current studies on the pathogenesis of melioidosis. Microbes Infect. 1:1999;157-162.
37. Sexton M.M., Jones A.L., Chaowagul W., Woods D.E. Purification and characterization of a protease from Pseudomonas pseudomallei. Can J Microbiol. 40:1994;903-910.
38. Haussler S., Nimtz M., Domke T., Wray V., Steinmetz I. Purification and characterization of a cytotoxic exolipid of Burkholderia pseudomallei. Infect Immun. 66:1998;1588-1593.
39. Egan A.M., Gordon D.L. Burkholderia pseudomallei activates complement and is ingested but not killed by polymorphonuclear leukocytes. Infect Immun. 64:1996;4952-4959.
40. Wong K.T., Puthucheary S.D., Vadivelu J. The histopathology of human melioidosis. Histopathology. 26:1995;51-55.
41. Kespichayawattana W., Rattanachetkul S., Wanun T., Utaisincharoen P., Sirisinha S. Burkholderia pseudomallei induces cell fusion and actin-associated membrane protrusion: a possible mechanism for cell-to-cell spreading. Infect Immun. 68:2000;5377-5384.
42. Stevens M.P., Wood M.W., Taylor L.A., et al. An Inv/Mxi-Spa-like type III protein secretion system in Burkholderia pseudomallei modulates intracellular behaviour of the pathogen. Mol Microbiol. 46:2002;649-659.
43. Rainbow L., Hart C.A., Winstanley C. Distribution of type III secretion gene clusters in Burkholderia pseudomallei, B thailandensis and B mallei. J Med Microbiol. 51:2002;374-384.
44. Walsh A.L., Smith M.D., Wuthiekanun V., et al. Prognostic significance of quantitative bacteremia in septicemic melioidosis. Clin Infect Dis. 21:1995;1498-1500.
45. Charuchaimontri C., Suputtamongkol Y., Nilakul C., et al. Antilipopolysaccharide II: an antibody protective against fatal melioidosis. Clin Infect Dis. 29:1999;813-818.
46. Steinmetz I., Rohde M., Brenneke B. Purification and characterisation of an exopolysaccharide of Burkholderia (Pseudomonas) pseudomallei. Infect Immun. 63:1995;3959-3965.
47. Reckseidler S.L., DeShazer D., Sokol P.A., Woods D.E. Detection of bacterial virulence genes by subtractive hybridization: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant. Infect Immun. 69:2001;34-44.
48. Haussler S., Rohde M., Steinmetz I. Highly resistant Burkholderia pseudomallei small colony variants isolated in vitro and in experimental melioidosis. Med Microbiol Immunol (Berl). 188:1999;91-97.
49. Jones S.M., Ellis J.F., Russell P., Griffin K.F., Oyston P.C. Passive protection against Burkholderia pseudomallei infection in mice by monoclonal antibodies against capsular polysaccharide, lipopolysaccharide or proteins. J Med Microbiol. 51:2002;1055-1062.
50. Santanirand P., Harley V.S., Dance D.A., Drasar B.S., Bancroft G.J. Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei. Infect Immun. 67:1999;3593-3600.
51. Brown A.E., Dance D.A.B., Suputtamongkol Y., et al. Immune cell activation in melioidosis: increased serum levels of interferon-gamma and soluble interleukin-2 receptors without change in soluble CD8 protein. J Infect Dis. 163:1991;1145-1148.
52. Suputtamongkol Y., Kwiatkowski D., Dance D.A.B., Chaowagul W., White N.J. Tumor necrosis factor in septicemic melioidosis. J Infect Dis. 165:1992;561-564.
53. Friedland J.S., Suputtamongkol Y., Remick D.G., et al. Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection. Infect Immun. 60:1992;2402-2408.
54. Simpson A.J.H., Smith M.D., Weverling G.J., et al. Prognostic value of cytokine concentrations (tumor necrosis factor, interleukin 6 and interleukin 10) and clinical parameters in severe melioidosis. J Infect Dis. 181:2000;621-625.
55. Lauw F.N., Simpson A.J., Prins J.M., et al. The CXC chemokines gamma interferon (IFN-gamma)-inducible protein 10 and monokine induced by IFN-gamma are released during severe melioidosis. Infect Immun. 68:2000;3888-3893.
56. Lauw F.N., Simpson A.J., Hack C.E., et al. Soluble granzymes are released during human endotoxemia and in patients with severe infection due to Gram-negative bacteria. J Infect Dis. 182:2000;206-213.
57. Nuntayanuwat S., Dharakul T., Chaowagul W., Songsivilai S. Polymorphism in the promoter region of tumor necrosis factor-alpha gene is associated with severe meliodosis. Hum Immunol. 60:1999;979-983.
58. Dharakul T., Vejbaesya S., Chaowagul W., Luangtrakool P., Stephens H.A., Songsivilai S. HLA-DR and -DQ associations with melioidosis. Hum Immunol. 59:1998;580-586.
59. Suputtamongkol Y., Chaowagul W., Chetchotisakd P., et al. Risk factors for melioidosis and bacteremic melioidosis. Clin Infect Dis. 29:1999;408-413.
60. Schulin T., Steinmetz I. Chronic melioidosis in a patient with cystic fibrosis. J Clin Microbiol. 39:2001;1676-1677.
61. Visca P., Cazzola G., Petrucca A., Braggion C. Travel-associated Burkholderia pseudomallei infection (Melioidosis) in a patient with cystic fibrosis: a case report. Clin Infect Dis. 32:2001;E15-E16.
62. Holland D.J., Wesley A., Drinkovic D., Currie B.J. Cystic fibrosis and Burkholderia pseudomallei infection: an emerging problem? Clin Infect Dis. 35:2002;138-140.
63. Suputtamongkol Y., Hall A.J., Dance D.A.B., et al. The epidemiology of melioidosis in Ubon Ratchatani, north eastern Thailand. Intl J Epidemiol. 23:1994;1082-1089.
64. Kanaphun P., Thirawattasuk N., Suputtamongkol Y., et al. Serology and carriage of Pseudomonas pseudomallei: a prospective study in 1000 hospitalised children in northeastern Thailand. J Infect Dis. 167:1993;230-233.
65. Wuthiekanun V., Smith M.D., Dance D.A., Walsh A.L., Pitt T.L., White N.J. Biochemical characteristics of clinical and environmental isolates of Burkholderia pseudomallei. J Med Microbiol. 45:1996;408-412.
66. Smith M.D., Angus B., Wuthiekanun V., White N.J. Arabinose assimilation defines a non-virulent biotype of Burkholderia pseudomallei. Infect Immun. 65:1997;4319-4321.
67. Brett P.J., DeShazer D., Woods D.E. Burkholderia thailandensis sp nov, a Burkholderia pseudomallei-like species. Int J Syst Bacteriol. 48:1998;317-320.
68. Inglis T.J., Garrow S.C., Adams C., Henderson M., Mayo M., Currie B.J. Acute melioidosis outbreak in Western Australia. Epidemiol Infect. 123:1999;437-443.
69. Currie B., Smith-Vaughan H., Golledge C., Buller N., Sriprakash K.S., Kemp D.J. Pseudomonas pseudomallei isolates collected over 25 years from a non-tropical endemic focus show clonality on the basis of ribotyping. Epidemiol Infect. 113:1994;307-312.
70. Lumbiganon P., Pengsaa K., Puapermpoonsiri S., Puapairoj A. Neonatal melioidosis: a report of 5 cases. Pediatr Infect Dis J. 7:1988;634-636.
71. Halder D., Abdullah W.A., Johari M.R., Choo K.E. Neonatal melioidosis. Singapore Med J. 34:1993;85-86.
72. Abbink F.C., Orendi J.M., de Beaufort A.J. Mother-to-child transmission of Burkholderia pseudomallei. N Engl J Med. 344:2001;1171-1172.
73. Green R.N., Tuffnell P.G. Laboratory acquired melioidosis. Am J Med. 44:1968;599-605.
74. McCormick J.B., Sexton D.J., McMurray J.G., Carey E., Hayes P., Feldman R.A. Human-to-human transmission of Pseudomonas pseudomallei. Ann Intern Med. 83:1975;512-513.
75. Vatcharapreechasakul T., Suputtamongkol Y., Dance D.A.B., Chaowagul W., White N.J. Pseudomonas pseudomallei liver abscesses: a clinical, laboratory, and ultrasonographic study. Clin Infect Dis. 14:1992;412-417.
76. Rode J.W., Webling D.D. Melioidosis in the Northern Territory of Australia. Med J Aust. 1:1981;181-184.
77. Thin R.N., Brown M., Stewart J.B., Garrett C.J. Melioidosis: a report of ten cases. Q J Med. 39:1970;115-127.
78. Siripanthong S., Teerapantuwat S., Prugsanusak W., et al. Corneal ulcer caused by Pseudomonas pseudomallei: report of three cases. Rev Infect Dis. 13:1991;335-337.
79. Dance D.A.B., Davis T.M.E., Wattanagoon Y., et al. Acute suppurative parotitis caused by Pseudomonas pseudomallei in children. J Infect Dis. 159:1989;654-660.
80. Woods M.L. 2nd, Currie B.J., Howard D.M., et al. Neurological melioidosis: seven cases from the Northern Territory of Australia. Clin Infect Dis. 15:1992;163-169.
81. Dhiensiri T., Puapairoj S., Susaengrat W. Pulmonary melioidosis: clinical-radiologic correlation in 183 cases in northeastern Thailand. Radiology. 166:1988;711-715.
82. Wibulpolprasert B., Dhiensiri T. Visceral organ abscesses in melioidosis: sonographic findings. J Clin Ultrasound. 27:1999;29-34.
83. Ramsay S.C., Labrooy J., Norton R., Webb B. Demonstration of different patterns of musculoskeletal, soft tissue and visceral involvement in melioidosis using 99m Tc stannous colloid white cell scanning. Nucl Med Commun. 22:2001;1193-1199.
84. Wuthiekanun V., Suputtamongkol Y., Simpson A.J.H., Kanaphun P., White N.J. Value of throat swab in the diagnosis of melioidosis. J Clin Microbiol. 39:2001;3801-3802.
85. Walsh A.L., Wuthiekanun V., Smith M.D., Suputtamongkol Y., White N.J. Selective broths for the isolation of Pseudomonas pseudomallei from clinical samples. Trans R Soc Trop Med Hyg. 89:1995;124.
86. Tiangpitayakorn C., Songsivilai S., Piyasangthong N., Dharakul T. Speed of detection of Burkholderia pseudomallei in blood cultures and its correlation with the clinical outcome. Am J Trop Med Hyg. 57:1997;96-99.
87. Simpson A.J.H., Howe P.A., Wuthiekanun V., White N.J. A comparison of lysis-centrifugation, pour plate and conventional blood culture methods in the diagnosis of septicaemic melioidosis. J Clin Pathol. 52:1999;616-619.
88. Smith M.D., Wuthiekanun V., Walsh A.L., Pitt T.L. Latex agglutination test for identification of Pseudomonas pseudomallei. J Clin Pathol. 46:1993;374-375.
89. Steinmetz I., Reganzerowski A., Brenneke B., Häuβler S., Simpson A., White N.J. Rapid identification of Burkholderia pseudomallei by latex agglutination based on an exopolysaccharide-specific monoclonal antibody. J Clin Microbiol. 37:1999;225-228.
90. Anuntagool N., Naigowit P., Petkanchanapong V., Aramsri P., Panichakul T., Sirisinha S. Monoclonal antibody-based rapid identification of Burkholderia pseudomallei in blood culture fluid from patients with community-acquired septicaemia. J Med Microbiol. 49:2000;1075-1078.
91. Walsh A.L., Smith M.D., Wuthiekanun V., et al. Immunofluorescence microscopy for the rapid diagnosis of melioidosis. J Clin Pathol. 47:1994;377-379.
92. Ashdown L.R., Johnson R.W., Koehler J.M., Cooney C.A. Enzyme linked immunosorbent assay for the diagnosis of clinical and subclinical melioidosis. J Infect Dis. 160:1989;253-260.
93. White N.J., Dance D.A., Chaowagul W., Wattanagoon Y., Wuthiekanun V., Pitakwatchara N. Halving of mortality of severe melioidosis by ceftazidime. Lancet. 2:1989;697-701.
94. Sookpranee M., Boonma P., Susaengrat W., Bhuripanyo K., Punyagupta S. Multicenter prospective randomized trial comparing ceftazidime plus co-trimoxazole with chloramphenicol plus doxycycline and co-trimoxazole for treatment of severe melioidosis. Antimicrob Agents Chemother. 36:1992;158-162.
95. Chaowagul W., Simpson A.J.H., Suputtamongkol Y., White N.J. Empirical cephalosporin treatment in melioidosis. Clin Infect Dis. 28:1999;1328.
96. Smith M.D., Wuthiekanun V., Walsh A.L., White N.J. Susceptibility of Pseudomonas pseudomallei to some newer β-lactam antibiotics and antibiotic combinations using time-kill studies. J Antimicrob Chemother. 33:1994;145-149.
97. Simpson A.J.H., Suputtamongkol Y., Smith M.D., et al. Comparison of imipenem and ceftazidime as therapy for severe melioidosis. Clin Infect Dis. 29:1999;381-387.
98. Suputtamongkol Y., Rajchanuwong A., Chaowagul W., et al. Ceftazidime vs amoxicillin/clavulanate in the treatment of severe melioidosis. Clin Infect Dis. 19:1994;846-853.
99. Chetchotisakd P., Porramatikul S., Mootsikapun P., Anunnatsiri S., Thinkhamrop B. Randomized, double-blind, controlled study of cefoperazone-sulbactam plus cotrimoxazole versus ceftazidime plus cotrimoxazole for the treatment of severe melioidosis. Clin Infect Dis. 33:2001;29-34.
100. Angus B.J., Smith M.D., Suputtamongkol Y., et al. Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion versus intermittent bolus injection in septicaemic melioidosis. Br J Clin Pharmacol. 49:2000;184-191.
101. Rajchanuvong A., Chaowagul W., Suputtamongkol Y., Smith M.D., Dance D.A.B., White N.J. A prospective comparison of co-amoxiclav and the combination of chloramphenicol, doxycycline, and co-trimoxazole for the oral maintenance treatment of melioidosis. Trans R Soc Trop Med Hyg. 89:1995;546-549.
102. Chaowagul W., Simpson A.J.H., Suputtamongkol Y., Smith M.D., Angus B.J., White N.J. A comparison of chloramphenicol, trimethoprim-sulfamethoxazole and doxycycline versus doxycycline alone in the maintenance treatment of melioidosis. Clin Infect Dis. 29:1999;375-380.
103. Currie B.J., Fisher D.A., Anstey N.M., Jacups S.P. Melioidosis: acute and chronic disease, relapse and re-activation. Trans R Soc Trop Med Hyg. 94:2000;301-304.
104. Suputtamongkol Y., Dance D.A.B., Chaowagul W., Wattanagoon Y., Wuthiekanun V., White N.J. Amoxycillin-clavulanic acid treatment of melioidosis. Trans R Soc Trop Med Hyg. 85:1991;672-675.
105. Chaowagul W., Suputtamongkol Y., Dance D.A.B., Rajchanuvong A., Pattara-arechachai J., White N.J. Relapse in melioidosis: incidence and risk factors. J Infect Dis. 168:1993;1181-1185.
106. Edmond K.M., Bauert P., Currie B.J. Paediatric melioidosis in the Northern Territory of Australia: an expanding clinical spectrum. J Paediatr Child Health. 37:2001;337-341.
107. Currie B., Fisher D.A., Howard Burrow J.N.C. Neurological melioidosis. Acta Trop. 74:2000;145-151.
108. Dance D.A.B. Melioidosis as an emerging global problem. Acta Trop. 74:2000;115-119.